Explore the detailed record of transactions filed by File Justin J., Chief Financial Officer. Officer active across 2 companies, notably Evofem Biosciences, Inc.. In total, 9 disclosures have been logged. Total volume traded: €68k. The latest transaction was disclosed on 18 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Justin J. File is the Chief Financial Officer at Evofem Biosciences, Inc. In this role, he is responsible for managing the company's finances, including financial planning and performance analysis. Justin plays a key role in preparing financial reports and managing financial risks.